Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3DIZ-guided Botox for post-stroke spasticity
NCT03302741Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Nov 2017
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum neurotoxin in spasticity, sponsored by UTHealth Houston. Started Nov 2017; status: completed.
02
Drugs
botulinum neurotoxin
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT03302741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03302741.